Tuesday, May 17, 2011

The Botox Conundrum

Bonnie - anytime you use poisonous substances, FDA-approved or not, the results can be good and bad. That has proven to be true with Botox.

The Good
  • A Journal Urology study assessed onabotulinumtoxinA (BOTOX®) in patients with idiopathic overactive bladder and urinary urgency incontinence whose symptoms were not adequately managed with anticholinergics. Efficacy was observed for all dose groups above 100 U or greater. The only adverse events significantly greater than placebo were urinary tract infection and urinary retention. Botox demonstrated durable efficacy in the management of idiopathic overactive bladder and urinary urgency incontinence. A dose of 100 U may be the dose that appropriately balances the symptom benefits with safety.
  • Scientists have developed a new way to refine Botox in an effort to improve its use for Parkinson's, cerebral palsy and chronic migraine. The new clipping method produced a refined botox-like molecule, which would be practical for clinical use but would not have unwanted toxic effects. Britain became the first country to approve Botox as a treatment for migraine. Its toxicity has so far limited its development for other clinical uses. The method could potentially allow researchers to develop a form of chronic pain relief which could last as long as a single botox injection - around four to six months, according to the Proceedings of the National Academy of Sciences study.
The Bad
  • In a huge settlement, $212 million dollars has been awarded to a victim of Botox, as Allergan the manufacturer, has conceded that the drug did cause a California man brain damage and disability. The man was given an injection of Botox in 2007 for treating a hand tremor and writer's cramp.
  • Botox may dull your ability to understand the emotions of others, a new study from Social Psychology and Personality Science suggests. Botox paralyzes muscles, hindering certain facial movements, such as frowns, that over time can cause wrinkles. Therein lies the problem, says the lead researcher. "If muscular signals from the face to the brain are dampened by Botox, you're less able to read emotions." Researchers conducted two experiments, one of 31 women, comparing Botox with Restylane, a dermal filler, and the other of 56 women and 39 men, using a gel that amplifies muscular signals. Participants in both experiments viewed computer images of faces and identified the emotions they saw. "When the facial muscles are dampened, you get worse in emotion perception, and when the facial muscles are amplified, you get better at emotion perception," researchers say. A similar study published last year in the journal Emotion said Botox injections may decrease a person's ability to feel emotions. The findings would suggest that facial expressions are an integral component of what we consider our emotional experience.
  • Americans are starting to see the doctor again, but more often for cosmetic procedures than for screenings and other potentially life-saving preventive care. Tthe facial aesthetics and even breast aesthetics markets are now at a place that we are beyond the peak pre-recession. Sales of Allergan's Botox are 20% above where they peaked before the recession.
  • A new study found that animals injected with Botox experienced muscle weakness in muscles throughout the body, even though they were far removed from the injection site. The study also found that repeated injection induced muscle atrophy and loss of contractile tissue in the limb that was not injected with the toxin. The study, which appears in The Journal of Biomechanics, raises some important questions about the long-term therapeutic use of Botox, especially with children and adolescents." The study used dosages that approximated therapeutic doses used to treat conditions like cerebral palsy where muscle contraction can't be controlled resulting in muscle dystonia and spasticity. This study shows, for the first time, that over time Botox use also results in muscle weakness, atrophy and loss of contractile tissue in non-injected muscles far-removed from the injection site.

No comments:

Post a Comment